About the Authors
- Niclas Franck
-
Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America
- Michael Maris
-
Affiliations Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America, Clinical and Experimental Endocrinology, Catholic University Leuven, Leuven, Belgium
- Sarah Nalbandian
-
Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America
- Saswata Talukdar
-
Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America
- Simon Schenk
-
Affiliation Department of Orthopedic Surgery, University of California San Diego, La Jolla, California, United States of America
- Hans-Peter Hofmann
-
Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America
- David Bullough
-
Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America
- Olivia Osborn
-
* E-mail: oosborn@ucsd.edu
Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America
Competing Interests
Antisense oligos against IL-1Ra were a gift from Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Please note, that some of the authors are affiliated with Pfizer, and these authors played a role in design, data collection and preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.
Author Contributions
Conceived and designed the experiments: HH DB OO. Performed the experiments: NF SN MM. Analyzed the data: OO. Contributed reagents/materials/analysis tools: HH DB ST. Wrote the paper: OO SS.